Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KN015 in Healthy Female Volunteers
NCT03192527Phase 1Unknown
- Sponsor
- Alphamab Oncology
- Start
- Jun 2017
- Primary completion
- Mar 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in female infertility comparing KN015 with Placebo (2 arms). Primary endpoints: Number of Participants With Abnormal Laboratory Values and/or Adverse Events That Are Related to Treatment(SAEs) and AEs of special interest up to 36 days, Maximum observed serum concentration and 6 more. Status: unknown.
02
Drugs
KN015
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT03192527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192527.